title: Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
authors.affiliation: 1Rheumatology Department, Royal Berkshire Hospital, Reading, UK.
authors.forename: J
authors.initials: J
authors.lastname: Bakshi
authors.forename: S
authors.initials: S
authors.lastname: Hassan
authors.forename: D
authors.initials: D
authors.lastname: D'Cruz
authors.forename: A
authors.initials: A
authors.lastname: Chan
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D055501:Macrophage Activation Syndrome / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab